JPWO2020099582A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020099582A5
JPWO2020099582A5 JP2021526247A JP2021526247A JPWO2020099582A5 JP WO2020099582 A5 JPWO2020099582 A5 JP WO2020099582A5 JP 2021526247 A JP2021526247 A JP 2021526247A JP 2021526247 A JP2021526247 A JP 2021526247A JP WO2020099582 A5 JPWO2020099582 A5 JP WO2020099582A5
Authority
JP
Japan
Prior art keywords
cancer
polypeptide
composition
seq
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021526247A
Other languages
English (en)
Japanese (ja)
Other versions
JP7611137B2 (ja
JP2022507373A5 (https=
JP2022507373A (ja
Publication date
Priority claimed from GBGB1818576.9A external-priority patent/GB201818576D0/en
Application filed filed Critical
Publication of JP2022507373A publication Critical patent/JP2022507373A/ja
Publication of JPWO2020099582A5 publication Critical patent/JPWO2020099582A5/ja
Publication of JP2022507373A5 publication Critical patent/JP2022507373A5/ja
Application granted granted Critical
Publication of JP7611137B2 publication Critical patent/JP7611137B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021526247A 2018-11-14 2019-11-14 免疫原性アルギナーゼ２ポリペプチド Active JP7611137B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1818576.9 2018-11-14
GBGB1818576.9A GB201818576D0 (en) 2018-11-14 2018-11-14 Arginase 2 polypeptides
PCT/EP2019/081369 WO2020099582A1 (en) 2018-11-14 2019-11-14 Immunogenic arginase 2 polypeptides

Publications (4)

Publication Number Publication Date
JP2022507373A JP2022507373A (ja) 2022-01-18
JPWO2020099582A5 true JPWO2020099582A5 (https=) 2022-08-30
JP2022507373A5 JP2022507373A5 (https=) 2022-08-30
JP7611137B2 JP7611137B2 (ja) 2025-01-09

Family

ID=64739444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021526247A Active JP7611137B2 (ja) 2018-11-14 2019-11-14 免疫原性アルギナーゼ２ポリペプチド

Country Status (11)

Country Link
US (2) US12234288B2 (https=)
EP (1) EP3880225A1 (https=)
JP (1) JP7611137B2 (https=)
KR (1) KR20210093287A (https=)
CN (1) CN113164545B (https=)
AU (1) AU2019378076B2 (https=)
CA (1) CA3118794A1 (https=)
GB (1) GB201818576D0 (https=)
IL (1) IL283133B1 (https=)
SG (1) SG11202104881VA (https=)
WO (1) WO2020099582A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201818576D0 (en) * 2018-11-14 2018-12-26 Io Biotech Aps Arginase 2 polypeptides
GB201912030D0 (en) * 2019-08-21 2019-10-02 Cancer Research Tech Ltd Binding molecules
WO2023161350A1 (en) 2022-02-24 2023-08-31 Io Biotech Aps Nucleotide delivery of cancer therapy
JP2025508840A (ja) 2022-02-24 2025-04-10 アイオー バイオテック エーピーエス アルギナーゼ２ワクチン

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US58767A (en) 1866-10-16 John brougjbton
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5780286A (en) * 1996-03-14 1998-07-14 Smithkline Beecham Corporation Arginase II
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US20070014801A1 (en) * 2001-01-24 2007-01-18 Gish Kurt C Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
AU2002215345A1 (en) * 2000-10-13 2002-04-22 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
PT3778885T (pt) * 2008-10-31 2023-05-31 Aerase Inc Composições de arginases humanas modificadas e métodos para o tratamento do cancro
CA2988388C (en) * 2015-04-23 2022-11-22 Nantomics, Llc Cancer neoepitopes
DK3423087T3 (da) * 2016-03-04 2023-12-18 Io Biotech Aps Kombinationsterapi mod cancer
GB2568000A (en) * 2016-08-08 2019-05-01 Aerase Inc Compositions and methods for treating cancer with arginine depletion and immuno oncology agents
JP7211938B2 (ja) * 2016-10-07 2023-01-24 アイオー バイオテック エーピーエス 免疫原性アルギナーゼペプチド
GB201815549D0 (en) 2018-09-24 2018-11-07 Io Biotech Aps Arginase1 polypeptides
GB201818576D0 (en) * 2018-11-14 2018-12-26 Io Biotech Aps Arginase 2 polypeptides

Similar Documents

Publication Publication Date Title
US5861381A (en) Pharmaceutical composition for the treatment of a malignant tumor
AU2003218600B2 (en) ERBB3 based methods and compositions for treating neoplasms
EP3094652B1 (en) Novel vaccines against hpv and hpv-related diseases
JP2022507373A5 (https=)
RU2007119319A (ru) Наборы антигенов полипептида, угнетающего секрецию желудка (gip), и их применение
JPH09512172A (ja) 保護的免疫応答及びｉｌ−１２産生の刺激及び促進のための化合物及び方法
JP7099956B2 (ja) がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種
CN111154806A (zh) 一种嵌合外源超级细胞因子的溶瘤病毒载体系统及其在药物中的应用
RU2017128465A (ru) Неприродные семафорины класса 3 и их медицинское применение
JP2017520556A (ja) 抗原ペプチドを投与するための組成物、方法、及び療法
CN106456728A (zh) 恢复对抗癌症的nkg2d通路功能的疫苗组合物和方法
JP2009538836A (ja) 生物活性の精製ＨｓｐＥ７組成物
JP6778697B2 (ja) 癌の治療のための免疫療法薬としての、組み換えマイコバクテリウム
JPWO2020099582A5 (https=)
CN118055775A (zh) 包括hsp90抗原肽的抗癌用疫苗组合物及其用途
CN101648011B (zh) 一种肿瘤靶向重组dna疫苗及其制备与应用
CN1482916A (zh) 含有转化生长因子α的疫苗组合物
US8207141B2 (en) Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
JPWO2020064744A5 (https=)
JPWO2020245264A5 (https=)
CN116390768A (zh) 具有抗癌活性的免疫调节蛋白-siRNA复合物
JP2015525785A (ja) 腫瘍治療のためのペプチドＥＧＦＲｖＩＩＩ配列に基づくワクチン
CN101061136A (zh) 具有白介素－2中和能力的免疫治疗制剂
CN102838679A (zh) Her2-neu抗原阳性肿瘤治疗性疫苗的制备及应用
US20030082201A1 (en) Multivalent synthetic vaccine for cancer